Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Receivables - Other (2018 - 2019)

Historic Receivables - Other for Puma Biotechnology (PBYI) over the last 2 years, with Q1 2019 value amounting to $9.9 million.

  • Puma Biotechnology's Receivables - Other changed N/A to $9.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $9.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2018, which is N/A changed from last year.
  • Latest data reveals that Puma Biotechnology reported Receivables - Other of $9.9 million as of Q1 2019.
  • In the past 5 years, Puma Biotechnology's Receivables - Other ranged from a high of $11.2 million in Q3 2018 and a low of $1.2 million during Q4 2018